| Literature DB >> 36018831 |
Junfang Sun1, Xue Li1, Zimeng Hu2, Xingfan Xue3, Miaomiao Zhang3, Qimin Wu1, Wei Zhang2, Yiquan Zhang1, Renfei Lu1.
Abstract
Vibrio parahaemolyticus is the leading cause of acute seafood-associated gastroenteritis worldwide. The aim of this study was to investigate the presence of virulence genes, biofilm formation, motor capacities and antimicrobial resistance profile of V. parahaemolyticus isolates isolated from clinical samples in Nantong during 2018-2020. Sixty-six V. parahaemolyticus strains isolated from stool specimens of diarrheal patients were examined. The PCR results showed that there were two tdh+trh+ isolates, four tdh-trh- isolates and sixty tdh+trh- isolates, accounting for 3.0%, 6.1% and 90.9%, respectively. All the tdh carrying isolates manifested the positive reactions for the Kanagawa phenomenon (KP) test. Most of the isolates harbored at least one of the specific DNA markers of 'pandemic group' strains, suggesting that the dominant isolates of V. parahaemolyticus in Nantong might belong to the new O3: K6 or its serovariants. All tdh+ isolates possessed the Vp-PAI genes, but no tdh-trh- isolates carried the T3SS2 genes. All isolates were biofilm producers and had relatively strong motor capacities. In addition, the V. parahaemolyticus isolates were resistant to ampicillin (98.5%), cefuroxime (75.6%), cefepime (66.7%), piperacillin (59.1%) and ampicillin/sulbactam (50.0%), but sensitive to ciprofloxacin (100.0%), levofloxacin (100.0%), trimethoprim-sulfamethoxazole (98.5%), gentamicin (98.5%), amikacin (97%), meropenem (71.2%), and ceftazidime (56.1%). Multidrug-resistant isolates in clinical might be related to the inappropriate use of antimicrobials in aquaculture.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36018831 PMCID: PMC9416985 DOI: 10.1371/journal.pone.0273700
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Primers used in this study.
| Target | Sequence (forward/reverse, 5ꞌ→3ꞌ) | Amplicon size (bp) | Reference |
|---|---|---|---|
|
| 651 | [ | |
|
| 235 | [ | |
|
|
| 683 | [ |
|
|
| 450 | [ |
|
|
| 269 | [ |
|
|
| 500 | [ |
|
|
| 579 | [ |
|
|
| 393 | [ |
|
|
| 362 | [ |
| VPA1376 |
| 1067 | [ |
| HU-a |
| 474 | [ |
|
|
| 464 | [ |
|
|
| 700 | [ |
|
|
| 368 | This study |
Presence of virulence genes in the 66 clinical V. parahaemolyticus isolates.
| Strain ID |
|
|
|
|
|
|
| HU-α |
|
|
| VPA1376 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VP5 | + | + | + |
| + | + | + | - | - | - | - | - | - | - |
| VP19 | + | + | + | - | + | + | + | - | - | - | - | - | - | - |
| VP2 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP3 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP4 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP6 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP8 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP9 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP10 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP11 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP12 | + | + | - | - | - | + | - | - | - | - | + | + | + | + |
| VP13 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP14 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP16 | + | + | - | + | - | + | - | + | + | + | + | + | + | + |
| VP17 | + | + | - | + | - | + | - | + | + | + | + | + | + | + |
| VP18 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP20 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP29 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP30 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP36 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP37 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP39 | + | + | - | - | - | + | - | - | - | - | + | + | + | + |
| VP40 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP41 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP42 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP43 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP44 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP45 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP46 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP47 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP48 | + | + | - | - | - | + | - | - | - | - | + | + | + | + |
| VP49 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP50 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP51 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP52 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP53 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP54 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP55 | + | + | - | - | - | + | - | - | - | - | + | + | + | + |
| VP56 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP57 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP58 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP59 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP60 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP61 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP62 | + | + | - | - | + | + | - | - | - | - | + | + | + | + |
| VP63 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP64 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP65 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP66 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP67 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP69 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP70 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP71 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP72 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP73 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP74 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP75 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP76 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP77 | + | + | - | + | + | + | - | + | + | + | + | + | + | + |
| VP78 | + | + | - | - | + | + | - | + | + | + | + | + | + | - |
| VP79 | + | + | - | - | - | + | - | - | - | - | + | + | + | + |
| VP80 | + | + | - | - | - | + | - | - | - | - | + | + | - | + |
| VP7 | + | - | - | - | - | + | - | - | - | - | - | - | - | - |
| VP15 | + | - | - | - | + | + | - | - | - | - | - | - | - | - |
| VP35 | + | - | - | - | + | + | - | - | - | - | - | - | - | - |
| VP68 | + | - | - | - | - | + | + | + | - | - | - | - | - | + |
Fig 1The hemolytic activity of V. parahaemolyticus isolates against RBCs was evaluated by observing whether there was a β-hemolysis zone surrounding the spot of growth on the Wagatsuma agar plate.
The pictures shown here are representative images of V. parahaemolyticus cells on Wagatsuma agar.
Biofilm formation by V. parahaemolyticus isolates at 30°C.
| Isolates | Total No. | Degree of biofilm formation (%, average OD ± SD) | Overall biofilm producers | ||
|---|---|---|---|---|---|
| Weak | Moderate | Strong | |||
|
| 2 | 1 (50.0%, 0.197 ± 0.022) | 1 (50.0%, 0.532 ± 0.051) | 0 | 2 (100.0%) |
|
| 60 | 6 (10.0%, 0.167 ± 0.017) | 29 (48.3%, 0.459 ± 0.086) | 25 (41.7%, 1.381 ± 0.966) | 60 (100.0%) |
|
| 4 | 0 | 4 (100.0%, 0.401 ± 0.056) | 0 | 4 (100.0%) |
Swimming motility of V. parahaemolyticus isolates.
| Isolates | Total No. | Degree of swimming ability (%, average mm ± SD) | Overall swimming producers | ||
|---|---|---|---|---|---|
| Weak | Moderate | Strong | |||
|
| 2 | 0 | 1 (50.0%, 7.000 ± 1.000) | 1 (50.0%, 10.667* ± 0.577) | 2 (100.0%) |
|
| 60 | 7 (11.7%, 3.405* ± 0.443) | 15 (25.0%, 6.233 ± 0.793) | 38 (63.3%, 10.550* ± 0.820) | 60 (100.0%) |
|
| 4 | 2 (50.0%, 3.750* ± 0.683) | 0 | 2 (50.0%, 8.833* ± 0.382) | 4 (100.0%) |
|
| 6.500 ± 0.500 | ||||
Swarming motility of V. parahaemolyticus isolates.
| Isolates | Total No. | Degree of swarming ability (%, average mm ± SD) | Overall swarming producers | ||
|---|---|---|---|---|---|
| Weak | Moderate | Strong | |||
|
| 2 | 0 | 2 (100%, 14.417 ± 0.382) | 0 | 2 (100.0%) |
|
| 60 | 0 | 12 (20.0%, 14.417 ± 0.458) | 48 (80.0%, 16.799* ± 0.675) | 60 (100.0%) |
|
| 4 | 0 | 2 (50.0%, 13.750 ± 0.433) | 2 (50.0%, 17.833* ± 0.866) | 4 (100.0%) |
|
| 14.167 ± 0.289 | ||||
Antibiotics resistance profiles of clinical V. parahaemolyticus isolates.
| Antibiotics | Number (%) of S | Number (%) of I | Number (%) of R |
|---|---|---|---|
| Ampicillin | 1 (1.5) | 0 (0.0) | 65 (98.5) |
| Ampicillin/sulbactam | 19 (28.8) | 14 (21.2) | 33 (50.0) |
| Piperacillin | 24 (36.4) | 3 (4.5) | 39 (59.1) |
| Piperacillin/tazobactam | 27 (40.9) | 9 (13.6) | 30 (45.5) |
| Cefazolin | 2 (3.0) | 45 (68.2) | 19 (28.8) |
| Cefuroxime | 0 (0.0) | 16 (24.2) | 50 (75.6) |
| Ceftazidime | 37 (56.1) | 0 (0.0) | 29 (43.9) |
| Cefepime | 22 (3.3) | 0 (0.0) | 44 (66.7) |
| Meropenem | 47 (71.2) | 0 (0.0) | 19 (28.8) |
| Amikacin | 64 (97.0) | 2 (3.0) | 0 (0.0) |
| Gentamicin | 65 (98.5) | 1 (1.5) | 0 (0.0) |
| Ciprofloxacin | 66 (100.0) | 0 (0.0) | 0 (0.0) |
| Levofloxacin | 66 (100.0) | 0 (0.0) | 0 (0.0) |
| trimethoprim-sulfamethoxazole | 65 (98.5) | 0 (0.0) | 1 (1.5) |